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ARTICLE
A CRISPR screen identiﬁes genes controlling Etv2
threshold expression in murine hemangiogenic fate
commitment
Haiyong Zhao1 & Kyunghee Choi 1,2
The ETS transcription factor Etv2 is necessary and sufﬁcient for the generation of hemato-
poietic and endothelial cells. However, upstream regulators of Etv2 in hemangiogenesis,
generation of hematopoietic and endothelial cells, have not been clearly addressed. Here we
track the developmental route of hemangiogenic progenitors from mouse embryonic stem
cells, perform genome-wide CRISPR screening, and transcriptome analysis of en route cell
populations by utilizing Brachyury, Etv2, or Scl reporter embryonic stem cell lines to further
understand the mechanisms that control hemangiogenesis. We identify the forkhead
transcription factor Foxh1, in part through Eomes, to be critical for the formation of FLK1+
mesoderm, from which the hemangiogenic fate is speciﬁed. Importantly, hemangiogenic fate
is speciﬁed not simply by the onset of Etv2 expression, but by a threshold-dependent
mechanism, in which VEGF-FLK1 signaling plays an instructive role by promoting
Etv2 threshold expression. These studies reveal comprehensive cellular and molecular
pathways governing the hemangiogenic cell lineage development.
DOI: 10.1038/s41467-017-00667-5 OPEN
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Integration of the extrinsic signals into lineage-speciﬁc geneexpression forms the basis for cell fate decisions. Accordingly,it is crucial to generate a comprehensive lineage map, to
identify extrinsic cues that guide a speciﬁc cell lineage outcome
and to delineate downstream signal cascades and transcriptional
networks involved in lineage speciﬁcation. Such information in
turn would facilitate efforts deriving a desired cell type from
pluripotent stem cells for regenerative medicine. To this end,
hematopoiesis, the generation of blood, offers a unique model to
study cell fate determination. While the lineage map downstream
of the hematopoietic stem cells (HSCs) has been extensively
described1, it is still largely unknown how HSCs themselves are
generated during embryogenesis.
Currently, it is well accepted that hematopoietic cells develop
from mesoderm through hemangiogenic progenitors2–4 and
hemogenic endothelium intermediates5–7. The close develop-
mental association between hematopoietic and endothelial cells is
manifested by many transcription factors and signaling pathways
that are commonly shared between these two cell populations.
Gene-targeting studies have also shown that mutations in any of
the shared genes often affect both cell lineages, supporting the
notion of the common genetic pathway regulating hematopoietic
and endothelial cell lineage development and function. Of these,
Etv2 (aka Er71 and etsrp) has emerged as an obligatory factor,
whose function is required at the earliest stage in hematopoietic
and vascular development. In particular, Etv2 deﬁciency leads to
embryonic lethality due to a complete block in blood and
endothelial cell formation. Conversely, enforced Etv2 expression
can ectopically activate both cell lineages8–10. These studies
support the notion that Etv2 functions at the core of the common
genetic pathway in blood and endothelial cell generation.
Therefore, Etv2-controlled hemangiogenesis provides a powerful
paradigm for modeling and assessing how exactly cell fate
determination can be achieved by a single factor.
In vitro differentiation model of embryonic stem (ES) cells,
which overcomes the cell number limitations for early embryonic
studies and allows large-scale genetic screening, has been exten-
sively used for studies pertaining to lineage development. To
understand cellular pathways and molecular mechanisms regulating
hemangiogenic cell lineage speciﬁcation, here we utilized T/Bra-
chyury, Etv2, and Scl expression together with PDGFRα and FLK1+
mesodermal markers to track hemangiogenic cell lineage develop-
ment during ES cell differentiation. We performed transcriptome
analysis of the transitional cell populations and high-throughput
clustered regularly interspaced short palindromic repeats (CRISPR)
screening11 to further understand upstream molecular events of
hemangiogenesis. Our data demonstrate a well-deﬁned develop-
mental route of hemangiogenesis, in which the forkhead tran-
scription factor Foxh1 regulates, functioning in part through Eomes,
FLK1+ mesoderm formation. The hemangiogenic fate is speciﬁed
within FLK1+ mesoderm by the Etv2 threshold expression, which
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Fig. 1 Etv2 threshold expression determines hemangiogenic fate. a Scheme of SGET ES cells. b Etv2-tdTomato and Scl-GFP expression in D4 SGET
EBs analyzed by ﬂow cytometry is shown on the left. The percentages of Scl-GFP+ cells (right side of the vertical dashed line) within Etv2-tdTomatohi(gh),
Etv2-tdTomatoint(ermediate) and Etv2-tdTomatoneg(ative) cells (shaded regions) are shown in the middle. Blast colony number obtained from sorted Etv2neg,
Etv2int, and Etv2hi cells is shown on the right. c Scheme of iEtv2-mCherry ES cell line. d iEtv2-mCherry EB cells differentiated in serum-free conditions
were analyzed for Etv2-mCherry and Scl-hCD4. –DOX, no DOX control, +DOX, DOX was added from D2.5 to D3.5 at a concentration of 2 μg/mL,
+DOX→ −DOX, DOX was added from D2.5 to D3.5, washed off and then cells were cultured for additional 2 days. –DOX and +DOX EBs were analyzed on
D3.5. +DOX→ −DOX EBs were analyzed on D5.5. e Flow cytometry plot of the four populations, 1 Etv2-tdTomatoint, 2 Etv2-tdTomatohi/Scl-GFP-(negative),
3 Etv2-tdTomatohiScl-GFPint, and 4 Scl-GFPhi from D4 SGET cells after sorting is shown. f Normalized relative mRNA level of Etv2 and Scl in the sorted
populations is shown. The mRNA level of Etv2 and Scl was ﬁrst normalized to Gapdh, and then the maximal value within the group was rescaled to 1.
g Violin plots showing fold changes of RNA-seq RPKM values of 73 ETV2 target genes in populations 2, 3, and 4, respectively, compared to population 1.
**P value <0.01 in Student’s t test, ***P< 0.001, and n= 3. Error bars are s.d
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Fig. 2 Developmental route of Etv2hi hemangiogenic progenitors. a FACS plot of Etv2-tdTomato and FLK1 in D4 SGET EBs is shown on the left. The
percentage of Etv2high cells within FLK1-negative or -positive cells is shown on the right. ***P value <0.001 in Student’s t test, n= 3. Error bars are s.d.
b Coexpression patterns of PDGFRα vs. T-GFP, FLK1 vs. T-GFP, and PDGFRα vs. FLK1, in D2.5 TGET EBs. c D3.5 SGET EBs treated with DMSO (control)
or ERK inhibitor PD0325901 (2 μM) were analyzed for PDGFRα and FLK1 expression by ﬂow cytometry. PD0325901 was added from D2.5 to 3.5.
d FACS sorting scheme of various mesodermal cell populations from D3.5 TGET EB is shown. T-GFP+PDGFRα-FLK1− (dn), T-GFP+PDGFRα+FLK1− (pr), and
PDGFRα+FLK1+ (dp). e Blast colony number obtained from various cell populations as sorted in d is shown. f Marker gene expression pattern in the sorted
populations as in d is shown. D0 indicates undifferentiated ES cells. g Indicated populations were sorted from E7.5 embryos and analyzed for relative
mRNA levels. h Comparative transcriptome analysis for indicated cell populations is shown. Three thousand eight hundred ﬁfteen genes that are expressed
in at least one sample and have a minimal RPKM change of 5-fold among the samples were chosen for comparison. ES undifferentiated mouse embryonic
stem cells, EpiSC ES cell-derived epiblast stem cells, “pr” and “dp” were already described in d; Etv2int, Etv2hiScl−, Etv2hiSclint, and Sclhi cells were described
in Fig. 1e; “cp”, ES cell-derived cardiac progenitors25. The D6 endoderm sample is not shown in the plot, but is included in the differential expression
analysis and Supplementary Data 2. i Schematic diagram shows a developmental route of ES cells to the Etv2-tdTomatohi(gh)/Scl-GFP+ hemangiogenic
state
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Results
Etv2 threshold expression determines hemangiogenic fate.
Given that Etv2 functions at the core of the genetic pathway in the
generation of hemangiogenic progenitor cells8–10, we reasoned
that tracking its expression would help delineate molecular and
cellular events leading to hemangiogenic cell lineage speciﬁcation.
Thus, we established a reporter ES cell line expressing tdTomato
and GFP from the Etv2 and Scl loci, respectively, to monitor
endogenous Etv2 and Scl expression (SGET ES cells, Fig. 1a).
Scl is a direct ETV2 target10, 12, 13 and is essential for hemato-
poietic lineage development14. As expected, the onset of Scl-GFP
expression in differentiating ES cells (embryoid bodies, EBs) was
later than that of Etv2-tdTomato (Supplementary Fig. 1a).
Importantly, emerging Scl-GFP+ cells were mainly observed
within cells expressing high levels of Etv2 (Etv2-tdTomatohigh),
suggesting an ETV2 threshold requirements in target gene
expression (Fig. 1b, left and middle). Consistently, blast-colony-
forming cells (BL-CFCs, representing hemangiogenic potential
in vitro)3, 15 were enriched in Etv2-tdTomatohigh cells, conﬁrm-
ing that hemangiogenic fate is speciﬁed in Etv2-tdTomatohigh
cells (Fig. 1b, right). Etv2-heterozygous cells still followed the
threshold rule (Supplementary Fig. 1b). The Scl-GFP+ cells
formed obvious bimodal distribution with time (Supplementary
Fig. 1c), suggesting an autoregulatory feedback mechanism for
Scl expression16. The hematopoietic marker CD41 and the
endothelial cell marker TIE2 expression were observed within
Scl-GFP+ cells (Supplementary Fig. 1c).
To further validate the threshold requirement of
Etv2 expression for the initiation of Scl expression, we established
an ES cell line that expresses doxycycline (DOX)-inducible
Etv2-mCherry, and human CD4 surface antigen from the
endogenous Scl locus17 (iEtv2-mCherry ES cells, Fig. 1c).
Enforced Etv2-mCherry expression activated Scl-hCD4 and
TIE2 in serum-free conditions, a differentiation system which
normally does not generate mesoderm cells unless BMP4 is
supplemented17. Importantly, an obvious threshold requirement
of Etv2 could be reconstituted in this condition (Fig. 1d, left and
middle, and Supplementary Fig. 1d). Etv2 expression level
in Etv2-mCherryhighScl-hCD4− cells were higher than in
Etv2-tdTomatohighScl-GFP− cells (Supplementary Fig. 1e). This
suggests that the exact threshold level of Etv2 expression
for activating Scl in different systems (endogenous vs. exogenous
or serum vs. serum free) may be different. Notably, Scl-hCD4+
cells were sustained after DOX withdrawal (Fig. 1d, right),
indicating establishment of an autoregulatory mechanism of
Scl expression.
To conﬁrm that hemangiogneic program is initiated
only after the Etv2 threshold expression is achieved, we sorted four
populations from SGET EBs, Etv2-tdTomatoint(ermediate), Etv2-
tdTomatohi(gh)Scl-GFP−, Etv2-tdTomatohi(gh)Scl-GFPint(ermediate),
and Scl-GFPhi(gh) (Fig. 1e). RT-qPCR showed that mRNA
levels of Etv2 were consistent to tdTomato reporter signals,
while Scl was activated mainly after Etv2 threshold was fulﬁlled
(Fig. 1e, f, left). We subsequently performed RNA-seq
analysis of the four populations. Out of genes that were upregulated
at least ﬁvefolds in Etv2-tdTomatohighScl-GFPint cells compared
to Etv2-tdTomatoint cells, 73 have been previously identiﬁed
to be ETV2 targets that included almost all the important
hemangiogenic genes10. The expression of these 73 ETV2
target genes became fully activated predominantly in Etv2-
tdTomatohighScl-GFP+ (Scl-GFPint or Scl-GFPhigh) cells (Fig. 1f,
right, and Supplementary Data 1), supporting the notion that
the hemangiogenic program becomes activated after the
Etv2 threshold expression is achieved. Collectively, Etv2
directly speciﬁes the hemangiogenic fate in a threshold-dependent
manner.
Developmental route to Etv2high hemangiogenic progenitors.
We next determined the developmental route generating
Etv2-tdTomatohigh hemangiogenic progenitor cells from plur-
ipotent cells. As T/Brachyury expression is ﬁrst detected in the
primitive streak/mesendoderm and persists in early mesoderm and
endoderm18, we established another ES cell line expressing GFP and
tdTomato from the endogenous T and Etv2 loci, respectively
(TGET ES cells, Supplementary Fig. 2a). To track Etv2 expression
dynamics during differentiation, we utilized two additional meso-
derm markers, the PDGF receptor α19, 20 and the VEGF receptor
FLK121, 22. While Etv2-tdTomatoint cells were observed in both
FLK1− and FLK1+ cells, Etv2-tdTomatohigh cells were found
predominantly within FLK1+ cells (Fig. 2a). Both FLK1+ and
PDGFRα+ cells were found within T-GFP+ cells in early EBs, day
2.75, conﬁrming their primitive streak origin (Fig. 2b, left and
middle). At this stage, FLK1+ cells were simultaneously PDGFRα
positive, (Fig. 2b, right). Moreover, PDGFRα single positive cells
could generate FLK1+ cells and CD41+ hematopoietic cells when
sorted and cultured on OP9 stromal cells (Supplementary Fig. 2b).
Furthermore, when differentiating EBs were treated with the Erk
map kinase inhibitor PD0325901 on D2.5, there was a block in
FLK1+ cell generation from PDGFRα single positive cells (Fig. 2c).
These results suggested that PDGFRα expression is a prerequisite
for that of FLK1, despite the fact that PDGFRα-FLK1−,
PDGFRα+FLK1−, and PDGFRα+FLK1+ cells were shown to be
highly plastic and interchangeable20.
To better delineate the relationship between T, Pdgfra, Flk1,
and Etv2, we sorted TGET EB cells into T-GFP+PDGFRα−FLK1−
(“dn”), T-GFP+PDGFRα+FLK1− (PDGFRα single positive, “pr”),
T-GFP+PDGFRα+FLK1+ (“dp”), and Etv2-tdTomatohigh cells
(“Etv2hi”) (Fig. 2d). As expected, BL-CFCs were enriched in
Etv2-tdTomatohigh cells (Fig. 2e). Analysis of marker gene
expression by RT-qPCR indicated that the pluripotency gene
Oct4 and mesendodermal/endoderm marker gene Foxa2 expres-
sion in “pr” cells was higher than in “dp” or “Etv2hi” cells. Etv2
expression was low in “dn” and “pr” cells, elevated in “dp” cells,
and achieving its highest expression in “Etv2hi” cells (Fig. 2f).
Therefore, compared to “dp” cells, “pr” cells are more similar to
“dn” cells, which might still represent the less differentiated
mesendoderm stage. Analysis of marker gene expression in “dn”,
“pr”, “dp”, and “ﬂ” (FLK1 single positive cells, which are enriched
for hemangiogenic lineage cells23) populations from E7.5
embryos further supported the interpretation that “pr” cells are
less differentiated than “dp” cells (Fig. 2g, right).
We next performed RNA-seq analysis of “pr” and “dp” cells,
and compared the data to those published RNA-seq of
undifferentiated ES cells, ES cell-derived epiblast stem cells
(EpiSCs), endoderm and cardiac progenitors (Fig. 2h)24–26. We
additionally included RNA-seq data from Etv2-tdTomatoint,
Etv2-tdTomatohighScl-GFP−, Etv2-tdTomatohighScl-GFPint, and
Scl-GFPhigh cell populations (described in Fig. 1e). Three
thousand eight hundred ﬁfteen genes were differentially
expressed in the 10 samples (Fig. 2h and Supplementary Data 2).
ES cells highly expressed pluripotency-related genes like Nanog,
Oct4, and Sox2 (group I), and EpiSCs expressed high levels of
mesendoderm/gastrulation-related genes like Foxa2 and Fgf5
(group II). While genes expressed in the primitive streak/early
mesoderm, such as T, Mesp1, Gsc, Pdgfra, Tbx6, and Mesp2,
were enriched in group III (“pr” cells), genes enriched in
groups VI and VII (hemangiogenic progenitors) or group VIII
(cardiac progenitors) still retained low expression in “pr” cells.
Therefore, gene expression proﬁling further suggests that “pr”
cells represent nascent/early mesoderm. Consistently, “pr”
transcriptome was more similar to the proximal regions of the
primitive streak of the E7.0 gastrulating embryo (Supplementary
Fig. 2c), where nascent mesoderm emerges, than “dp” cells, while
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transcriptome of ES cell-derived endoderm was more similar to
the distal regions, which form deﬁnitive endoderm27. To further
validate our transcriptome analysis, we additionally compared
our data with a published transcriptome proﬁling of multiple
stages in ES cell differentiation, which included ES cells, T+FLK1−
cells (“mes”), FLK1+ cells (“hb”), CD41−Tie2+Kit+ hemogenic
endothelial cells (“he”), and CD41+ hematopoietic progenitor
cells (“hp”)28. The “mes” cells should contain both “dn” and “pr”
populations, while the “hb” population should include all of the
Etv2−/int/hi cells in FLK1+ populations. Data analysis revealed that
“pr”-enriched genes (group III) were also enriched in “mes” cells
in this published data set, with 36 out of 80 achieving their
highest expression at this stage (Supplementary Fig. 2d, left, and
Supplementary Data 3). Similarly, the 97 “dp”-enriched genes
(group IV) were also extensively expressed in “hb” cells, with
48 of them achieving their highest expression there (Supplemen-
tary Fig. 2d, right, and Supplementary Data 4). Strikingly,
when only transcription-related genes were included29, “mes”
transcriptome was closer to “EpiSCs” than “pr”, while the
“hb” transcriptome ﬁtted in right between “dp” and “Etv2int”
samples (Supplementary Fig. 2e and Supplementary Data 5).
Meanwhile, the “hp” and “he” transcriptome were closer to our
Etv2-tdTomatohighScl-GFP+ sample (Supplementary Fig. 2e and
Supplementary Data 5). From these analyses, we propose that
hemangiogenic progenitors (ETV2highSCL+) develop from the
pluripotent stage through the following developmental route:
gastrulating mesendoderm (T-GFP+), nascent/early mesoderm
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Fig. 3 CRISPR screening identiﬁes key Etv2 upstream regulators. a Scheme for CRISPR screening. b FACS plot of the Etv2high and PDGFRα+ cells from
D3.5 TGET EB cells used for cell sorting after CRISPR library infection is shown. c Comparative reads analysis between TGET ES cells (24 h post infection,
“lib”) and stabilized TGET ES cells (2 weeks selection post infection, “input”), which shows depletion of gRNAs against essential genes for pluripotency in
stabilized TGET ES cells. d Comparative reads analysis between stabilized TGET ES cells (“input”) and PDGFRα+ cells, which shows depletion of gRNAs
against essential genes for PDGFRα+ mesoderm differentiation. e Comparative reads analysis between PDGFRα+ and Etv2high cells, which shows depletion
of gRNAs against genes essential for Etv2high cell generation. f Scheme for generation of the candidate gene list. Top 500 genes with depleted reads from
PDGFRα+ to Etv2high cells were compared to 10,402 genes expressed in mesoderm (with RPKM >1 in any of “pr”, “dp”, Etv2int, or Etv2highScl−), which
yielded 215 genes. g Functional annotation of selected candidate genes is shown. Numbers at the end of each bar shows the P value of gene enrichment in
the corresponding ontology item. h Validation of chosen candidate genes. The ratio of PDGFRα+ to Etv2high cells by a candidate sgRNA depletion was
normalized to that of empty vector. Refer to Supplementary Fig. 3b, c for more details. *P value <0.05 in Student’s t test, **P< 0.01, ***P< 0.001, and
n= 3. Error bars are s.d
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CRISPR screening identiﬁes Etv2 upstream signals. Having
deﬁned the developmental route giving rise to Etv2high heman-
giogenic progenitor cells, we employed high-throughput loss-of-
function screening utilizing the CRISPR/Cas9 system to identify
upstream factors regulating generation of this population. We
ﬁrst established TGET ES cells stably expressing the
Cas9 nuclease. Subsequently, we infected the cells with the
GeCKO-v2 lenti-CRISPR virus library A, which contained 66,405
gRNAs against 20,608 mouse protein-coding genes and 1145
miRNAs11. We collected four samples from the library-infected
cells (Fig. 3a, b): “lib”, 24 h post infection, “input”, 2 weeks post
infection, “pr” and “Etv2high” cells sorted from “input”-derived
EBs. The sample “lib” reﬂected the library complexity. While
gRNAs against genes essential for cell viability or pluripotency
maintenance should have been depleted in “input”, gRNAs
against genes required for Etv2-tdTomatohigh cell generation but
not for early mesoderm commitment should have been depleted
speciﬁcally in “Etv2high” cells. We recovered and sequenced
gRNAs from the four samples. The resulting gRNA counts
and the ranks of individual genes were analyzed using HiTSelect,
an analysis tool for pooled RNAi or CRISPR screening30
(Supplementary Data 6).
As expected, the top 1000 genes that were depleted in their
gRNAs from “lib” to “input” were enriched for those involved in
essential cell activities, such as DNA replication, transcription,
mRNA splicing, and translation (Supplementary Fig. 3a).
These also included the critical pluripotency-related genes such
as Oct4 and Nanog (Fig. 3c and Supplementary Data 7). From
“input” to “pr”, top ranked genes with depleted gRNAs included
the lysine methyltransferase Ezh2 of the polycomb group complex
PRC2, and components of the nonsense-mediated mRNA decay
pathway genes including Smg5, Smg6, and Smg7 (Fig. 3d and
Supplementary Data 8), which are required for early embryo
development and ES cell differentiation31. Smad232, one of the
transcription factors mediating TGFβ signaling to induce early
mesoderm and endoderm commitment, also ranked high in the
list.
High-ranking genes that were depleted in their gRNAs
in Etv2high cells compared to “pr” cells included the bone
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Fig. 4 Foxh1 is required for FLK1+ mesoderm generation. a Relative mRNA levels of Foxh1 in indicated cell populations sorted from D4 EBs are shown.
b Relative mRNA levels of Foxh1 in indicated cell populations sorted from E7.5 embryos are shown. c FACS analysis of D4 wild type (wt) and ΔFoxh1 EB cells
is shown. (Top and middle, SGET cells; bottom, TGET cells). d iFoxh1-ΔFoxh1 cells were differentiated with 500 ng/mL DOX, “dn”, “pr” and “dp” cells were
sorted on D3, and re-seeded onto OP9 cells with or without 500 ng/mL of DOX. Cells were analyzed 24 h later by ﬂow cytometry. The results are
summarized in e. f Spearman correlation map of RNA-seq data of transcription-related factors from indicated populations. g Comparison of RNA-seq
results of “pr-” or “dp”-enriched genes in ΔFoxh1 “pr”, wt “pr”, “dp”, and undifferentiated ES cells is shown. h Expression of key transcription factors with
highest expression in “dp” (identiﬁed in Fig. 2g) was validated by qRT-PCR using ΔFoxh1 “pr” and wt “dp” cells. i GSEA analysis of T-related genes41 for
downregulation in ΔFoxh1-pr vs. wt-pr cells. Only genes related to T with correlation scores >0.2 were chosen for GSEA analysis. NES normalized
enrichment score, FDR false discovery rate. *P value <0.05 in Student’s t test, **P< 0.01, ***P< 0.001, and n= 3. Error bars are s.d
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the generation of FLK1 and Scl-positive cells33, 34, the
VEGF receptor Flk1 (Kdr), which is critical for hematopoietic
and endothelial cell development35, and the transcription factor
Foxh1, which has been reported to be a cofactor for Smad2/336, 37
(Fig. 3e and Supplementary Data 9). By selecting genes highly
expressed in mesoderm (“dn”, “pr”, or “dp” cells), we narrowed
down 500 hits to 215 genes, which were enriched
for development-related genes (Supplementary Data 10 and
Fig. 3f, g). From this 215 gene list, which also included miRNAs,
we chose 10 genes for further validation. We also included
Hey238, which functions potentially in early embryonic heman-
giogenesis but not ranking high in the screening, and Plcd4,
which ranked high in screening but without enriched expression
in mesoderm. Out of these, gRNAs for 6 of the 12 genes
signiﬁcantly reduced the ratio of Etv2-tdTomatohigh cells to “pr”
cells (Fig. 3h and Supplementary Fig. 3b, c). gRNAs against
Flk1 and Foxh1 exhibited the most signiﬁcant reduction in
Etv2high cell generation.
Foxh1 is required for FLK1+ mesoderm generation. Foxh1
deﬁciency leads to early embryonic lethality due to abnormal
patterning in gastrulation36, 37. Therefore, its direct role in
hemangiogenesis has not been revealed. Foxh1 expression
increased gradually during EB development, peaking in “dp” cells
(Fig. 4a). Similarly, Foxh1 expression was higher in “dp” cells
compared to “dn” or “pr” cells in E7.5 embryos (Fig. 4b). To
investigate the role of Foxh1 in the Etv2high cell generation, we
generated Foxh1 knockout TGET and SGET ES cells by utilizing
the CRISPR/Cas9 system (ΔFoxh1 TGET/ΔFoxh1 SGET
ES cells). Foxh1 deﬁciency severely blocked Etv2-tdTomato
and FLK1 expression, while T-GFP+ and “pr” cells were
still produced, although at somewhat reduced levels (Fig. 4c).
Since “pr” cells still developed from ΔFoxh1 TGET ES cells,
we determined if Foxh1 deﬁciency leading to Etv2high cell
generation defect was at the level of FLK1+ mesoderm
formation from “pr”. We established a DOX-inducible Foxh1
expression system using ΔFoxh1 ES cells (iFoxh1-ΔFoxh1
ES cells), which expresses exogenous Foxh1 in a DOX-inducible
manner in the context of endogenous Foxh1 deﬁciency (Supple-
mentary Fig. 4a). First, exogenous Foxh1 expression in
ΔFoxh1 EBs could rescue FLK1+ mesoderm (Supplementary
Fig. 4b). We next sorted “pr” cells from D3 Foxh1-rescued
ΔFoxh1 EBs and further cultured them on OP9 cells. While
FLK1+ cells were robustly generated in the presence of DOX, very
few FLK1+ cells were generated without DOX (Fig. 4d, middle,
results summarized in Fig. 4e). This suggests that Foxh1
is essential for directly generating FLK1+ mesoderm from “pr”
cells. Moreover, while still able to produce “pr” cells, “dn” cells
could not generate FLK1+ cells without DOX. Importantly,
almost all “dp” cells even reverted back to “pr” or “dn”
stages without DOX, suggesting that Foxh1 is also required for
maintaining the “dp” state. Intriguingly, Foxh1 overexpression
in the context of wild-type background inhibited FLK1+ cell
generation (Supplementary Fig. 4c), although this was in line with
previous studies in zebraﬁsh39. Collectively, these studies suggest
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Fig. 5 Eomes functions downstream of Foxh1 in FLK1+ cell generation. a TGET ΔFoxh1 ES cells (BFP positive) were differentiated either by themselves (left) or
with wild-type A2lox ES cells (BFP negative, right). Subsequently, BFP-negative (wild type) or BFP-positive (ΔFoxh1) cells were analyzed for FLK1, T-GFP,
and Etv2-tdTomato expression on D4. b iFoxh1-ΔFoxh1 EB cells were treated with 500 ng/mL DOX for different time span as indicated and analyzed
by ﬂow cytometry on D3.5. c RT-qPCR analysis of indicated genes in D3.5 iFoxh1-ΔFoxh1 EB cells treated with 500 ng/mL DOX for different time span.
Frzb and Smad1, two signaling factors important for mesoderm development were included in the list. d RT-qPCR analysis of Etv2 was performed using
iFoxh1-ΔFoxh1 ES cells differentiated with or without DOX (500 ng/mL, D2.5–3.5), and then for additional 1 day without DOX. e Eomes mRNA levels in
indicated populations sorted from D3.5 TGET EBs and undifferentiated ES cells (“d0”) are shown. f Eomes mRNA levels are shown in indicated populations
sorted from E7.5 embryos. g Flow cytometry analysis of D3.5 iEomes-ΔFoxh1 EB cells treated with or without 50 ng/mL DOX for 24 h. h RT-qPCR analysis
of Etv2 was performed using iEomes-ΔFoxh1 ES cells differentiated with or without DOX (50 ng/mL, D2.5–3.5), and then for additional 1 day without DOX.
*P value <0.05 in Student’s t test, **P< 0.01, ***P< 0.001, and n= 3. Error bars are s.d
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To further understand how Foxh1 regulates FLK1+ mesoderm
generation, we compared transcriptome of Foxh1-deﬁcient “pr” cells
to those of wild-type mesoderm intermediates (“dn”, “pr”, or “dp”)
(Fig. 4f and Supplementary Datas 11, 12). Overall, the gene
expression pattern ofΔFoxh1 “pr” cells was close to other mesoderm
samples. Most of the nascent/early mesoderm genes enriched in “pr”
cells were already upregulated in ΔFoxh1 “pr” cells, but at a reduced
level compared to wild-type “pr” cells (Fig. 4g, Supplementary
Fig. 4d, top, and Supplementary Data 11). In particular, most of the
genes enriched in “dp” cells were more prominently reduced in
ΔFoxh1 “pr” cells compared to wild-type “dp” cells (Supplementary
Fig. 4d, bottom, and Supplementary Data 11). Among the
transcription factors that were extensively expressed in “dp” cells,
Mixl1, Eomes, Tbx3, Gsc, and Mesp1 expression was signiﬁcantly
reduced in ΔFoxh1 “pr” cells compared to wild-type “dp” cells
(Fig. 4h). Therefore, not just the surface marker FLK1, but the
speciﬁc transcriptional program in FLK1+ mesoderm, was blocked
by the Foxh1 deﬁciency. Consistent with Foxh1’s role in gastrulation,
gene set enrichment analysis (GSEA)40 of genes downregulated in
ΔFoxh1 “pr” cells showed signiﬁcant enrichment of genes that
correlate to T expression in the early gastrulating embryo41 (Fig. 4i
and Supplementary Fig. 4e). These ﬁndings reinforce the notion that
Foxh1 is required for FLK1+ mesoderm induction.
Eomes functions downstream of Foxh1 in FLK1+ cell genera-
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Fig. 6 VEGF-FLK1 signaling regulates Etv2 threshold expression. a Wild-type (wt) SGET ES cells were differentiated in different concentrations of VEGF and
analyzed for Etv2-tdTomato and Scl-GFP expression on D4. VEGF was added from D3–4. b Flow cytometry analysis of ETV2-mCherry and FLK1 in D3.5
iEtv2-mCherry EB cells differentiated in serum-free conditions. DOX (2 μg/mL) was added from D2.5 to D3.5. c Flow cytometry analysis of D4 wt and ΔFlk1
SGET EB cells for Etv2-tdTomato and FLK1 expression is shown. d Scheme of co-differentiation of wt and ΔFlk1 SGET ES cells is shown. wt and ΔFlk1 SGET ES
cells were mixed at a 4:1 ratio and co-differentiated as described in Experimental procedures. e Response of wt and ΔFlk1 SGET D4 EB cells to VEGF is shown
as Etv2high cell generation. VEGF (50 ng/mL) was added from D3–4. BFP-negative cells depict wt and BFP-positive cells depict ΔFlk1 cells. f Percentages of
Etv2int and Etv2high cells within wt and ΔFlk1 SGET EB cells. g Sorted populations as indicated from D4 SGET EBs were re-seeded onto OP9 cells and
analyzed 12 h later for Etv2-tdTomato and Scl-GFP by ﬂow cytometry. h Live imaging of SGET cells responding to VEGF. Black regions in the pictures are
occupied by Etv2-tdTomatonegative cells, Etv2-tdTomatoint cells are in red and Etv2-tdTomatohi cells are in orange. (i) FACS plot of D3 Flk1GFP/GFP EB cells
used for cell sorting, PDGFRα−GFP− (dn), PDGFRα+GFP- (pr), PDGFRα+GFP+ (dp), and PDGFRα−GFP+ (ﬂ) cells, is shown. Etv2 expression in “dn”, “pr”, and
“dp” cells isolated from D3 Flk1GFP/GFP EB cells is shown in j. k A model showing hemangiogenic progenitor development. The blue circles indicate different
stages during mesoderm differentiation (ES undifferentiated ES cells, ME mesendoderm, EM early mesoderm, LM lateral mesoderm, HA hemangiogenic
progenitors). The zigzag curves at the top indicate the stochastic ﬂuctuation of Etv2 expression. Activation of the hemangiogenic program rarely occurs in the
absence of VEGF signaling (blue line). However, when the VEGF signaling is active, the hemangiogenic fate can be efﬁciently achieved through the promotion
of Etv2 threshold expression (red line). *P value < 0.05 in Student’s t test, ***P< 0.001, and n= 3. Error bars are s.d
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expression of nodal, a critical morphogen driving gastrulation
and commitment of mesoderm and endoderm36, 37. To determine
if the defect in FLK1+ mesoderm generation by Foxh1 deﬁciency
is cell non-autonomous through nodal production, ΔFoxh1
TGET ES cells were mixed with wild-type ES cells and differ-
entiated. Wild-type cell supplementation did not rescue FLK1+
mesoderm from ΔFoxh1 TGET EBs (Fig. 5a). Therefore, Foxh1
was intrinsically required for FLK1+ mesoderm induction.
Although Foxh1 could rescue FLK1+ mesoderm, Flk1 and Etv2
were not likely to be FOXH1 direct target genes, as upregulation
of Flk1 was observed 24 h after DOX addition, while upregulation
of Etv2 was even later (Fig. 5b–d). To identify potential
intermediate gene(s) downstream of Foxh1, we analyzed response
of “pr-” and “dp”-enriched transcription factors or transcription-
related genes that were reduced in ΔFoxh1 “pr” cells (Fig. 4g
and Supplementary Data 11), and became rescued by exogen-
ous Foxh1 expression (Fig. 5c). Among the genes showing
upregulation after 8 h of DOX treatment, Eomes is a target for
FOXH142, 43, and is required for normal embryonic mesoderm
development44, 45. As Eomes expression was enriched in
“dp” cells from EBs and E7.5 embryos (Fig. 5e, f), we determined
if Eomes functions also downstream of Foxh1 in FLK1+
mesoderm generation from “pr” nascent mesoderm. Thus,
we established Eomes-inducible ES cell line in the background
of Foxh1 knockout (iEomes-ΔFoxh1). As shown, exogenous
Eomes expression was able to rescue FLK1+ cells, although
not fully, from Foxh1-deﬁcient cells (Fig. 5g). After Eomes
induction, Etv2 was also upregulated (Fig. 5h). Collectively,
Eomes functions downstream of Foxh1 in FLK1+ mesoderm
generation.
VEGF-FLK1 signaling regulates Etv2 threshold expression. The
ﬁnding that the VEGF receptor Flk1 ranked on top among genes
required for generating Etv2-tdTomatohigh cells suggested that
FLK1 functions upstream of Etv2. This notion is consistent with
previous studies, which demonstrated that VEGF was able to
activate Etv2 expression12, 46. However, Flk1 knockout embryos
or ES cells can still generate hematopoietic progenitors, although
limited35, 47, 48. This suggests that Etv2-mediated hemangiogenic
program commitment may occur independently of VEGF-FLK1
signaling. Intriguingly, Etv2-tdTomatohigh cells were noticeably
increased in the FLK1+ population in response to VEGF (Fig. 6a,
top). Enhanced generation of Etv2-tdTomatohigh cells by VEGF in
the FLK1+ cells led to more Scl-GFP+ cells (Fig. 6a, bottom).
Meanwhile, Etv2high cells reinforced FLK1 levels (Fig. 6a, b),
consistent with previous studies that ETV2 can directly activate
Flk18, 10, 23. To better elucidate the relationship between Etv2 and
Flk1, we generated Flk1 knockout SGET ES cells using the
CRISPR/Cas9 system (ΔFlk1 SGET ES cells). As shown, ΔFlk1 ES
cells efﬁciently expressed Etv2, suggesting an independent reg-
ulation of Etv2 from Flk1 (Fig. 6c). However, Etv2-tdTomatohigh
cells were predominantly found in FLK1+ cells and they were
speciﬁcally missing in ΔFlk1 cells (Fig. 6c). Moreover, when
mixed and co-differentiated together with wild-type ES cells (BFP
negative) (Fig. 6d), ΔFlk1 ES cells (BFP positive) very rar-
ely generated Etv2-tdTomatohigh cells, even though
Etv2-tdTomatoint cells were readily observed (Fig. 6e, left). While
wild-type cells, i.e., BFP negative, were signiﬁcantly elevated into
the Etv2high state by VEGF, ΔFlk1 cells, i.e., BFP positive, showed
no response to VEGF (Fig. 6e, right, summarized in Fig. 6f).
Consistently, SGET cells infected with lentivirus expressing gRNA
against Flk1 (BFP positive) produced signiﬁcantly reduced levels
of Scl-GFP+ cells compared to un-infected cells (Supplementary
Fig. 5a). Therefore, VEGF-FLK1 signaling is required for Etv2high
cell generation, not for the initiation of Etv2 expression, and a
reciprocal promotion between FLK1 and Etv2 might maintain the
cells in the Etv2-tdTomatohigh state.
We next determined if VEGF signaling directly promotes
Etv2high cells from Etv2int cells. Compared to Etv2-tdTomato−
“pr” and Etv2-tdTomato− “dp” cells, Etv2-tdTomatoint cells,
when re-seeded onto OP9 cells, could generate more Etv2-
tdTomatohigh cells (Fig. 6g). Furthermore, we observed direct
elevation of tdTomato expression in Etv2-tdTomatoint cells into
Etv2-tdTomatohigh cells in the presence of VEGF (Fig. 6h). To
further conﬁrm VEGF’s role in Etv2 expression, we generated
Vegfa knockout SGET cells using the CRISPR/
Cas9 system (ΔVegfa SGET ES cells). We induced mesoderm
differentiation with BMP4 in serum-free conditions33 (Supple-
mentary Fig. 5b, c). In this assay, ΔVegfa cells reproduced the
phenotype of ΔFlk1 cells, while a supplement of exogenous VEGF
rescued the generation of Etv2-tdTomatohigh and Scl-GFP+ cells.
We noticed that even without VEGFA supplementation, Etv2 was
still efﬁciently expressed in FLK1+ cells, although not efﬁciently
achieving the threshold expression (Supplementary Fig. 5c),
again demonstrating the VEGF role in the generation of
Etv2-tdTomatohigh cells.
To explore the dynamics of VEGF-FLK1 signaling-indepen-
dent Etv2 expression, we utilized the Flk1GFP/GFP ES cell line49.
This cell line in differentiation showed a similar coexpression
pattern of PDGFRα and GFP as PDGFRα and FLK1 in wild-type
cells, indicating that GFP expression faithfully reﬂected that of
Flk1 (Fig. 6i). As expected, very few GFP single positive cells, in
which Etv2 expression and hemangiogenic progenitors were
enriched10, 23, were generated from Flk1GFP/GFP ES cells (Fig. 6i).
We sorted PDGFRα and GFP (FLK1) double negative cells
(“dn”), PDGFRα single positive cells (“pr”), PDGFRα and GFP
double positive cells (“dp”), and GFP single positive cells (“ﬂ”),
and measured Etv2 expression by qRT-PCR. Remarkably, Etv2
expression was readily upregulated in PDGFRα+GFP+ cells
compared to “pr” cells, similar to that in PDGFRα+FLK1+ cells,
suggesting VEGF-FLK1 signaling-independent Etv2 expression
was initiated mainly in the presumptive FLK1+ mesoderm (GFP+
cells) (Fig. 6j). Very rare GFP single positive cells expressing
higher level Etv2 can still be made, probably through stochastic
mechanisms. Collectively, FLK1+ mesoderm is enriched for
Etv2 basal level expression and VEGF-FLK1 signaling instructs
hemangiogenic fate speciﬁcation by ensuring Etv2 threshold
expression.
Discussion
In this study, we provide mechanisms by which hemangiogenic
lineage commitment is achieved. In particular, by tracking Etv2
and Scl reporter expression and by comparing transcriptome
of various mesodermal cell populations, we were able to
delineate the developmental route generating hematopoietic and
endothelial cells via T/Bry+PDGFRα−FLK1−, T/Bry+PDGFRα+
FLK1−, PDGFRα+FLK1+, FLK1+Etv2int, FLK1+Etv2high, to
Etv2highScl+ cells. In this process, achievement of Etv2 threshold
expression is key to the hemangiogneic lineage speciﬁcation.
Currently, FLK1 expression is widely used as a hemangiogenic
lineage marker28, 41, 50. However, the highly reﬁned lineage route
established in this study indicates that hemangiogenic progenitors
represent a small fraction of FLK1+ cells. Therefore, in the future,
this improved lineage map should be helpful to isolate relevant
cell populations to further deﬁne gene regulatory network
involved in hematopoietic and vascular lineage development.
PDGFRα has been extensively used as paraxial mesoderm
marker20, 51. In particular, Sakurai et al. have suggested that
FLK1+PDGFRα+ mesoderm represents nascent mesoderm, from
which both FLK1+ lateral plate mesoderm and PDGFRα+ paraxial
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mesoderm are generated20. However, they also established that
“dn”, “pr”, and “dp” cells are developmentally plastic and
interchangeable in culture. Moreover, PDGFRα expression marks
nascent mesoderm in gastrulating mouse embryos52. Our
transcriptome analysis revealed that “pr” cells are close to
T+ PDGFRα−FLK1− mesendoderm and the proximal nascent
mesoderm of the primitive streak of the E7.0 gastrulating
embryo27. Furthermore, FLK1+PDGFRα+ mesoderm has cardiac
potential19, 23. These data support that “pr” cells represent
nascent/early mesoderm from which “dp” cells arise. Con-
sistently, we found that loss of Foxh1 or treatment with the ERK
inhibitor blocked progression of “pr” cells to “dp” state. Poten-
tially, later arising “pr” cells could include PDGFRα+ paraxial
mesoderm and cardiac progenitors. However, we cannot rule out
the possibility that FLK1+PDGFRα+ cells can also be generated
directly from mesendoderm when optimal stimuli for “dn” and
“dp” stages are simultaneously available. Future studies are
warranted to show the in vivo relationship between PDGFRα+
cells and FLK1+ cells.
Currently, upstream signals that activate Etv2 have not been
clearly elucidated. It appears that ETV2 positively regulates its
own expression10, 53. The cAMP-PKA-CREB, Calcineurin-NFAT,
MESP1-CREB1, VEGF-p38 MAPK-CREB, as well as NKX2-5
have been suggested to activate Etv210, 46, 53–56. In this paper, we
applied CRISPR/Cas9 genome-wide screening to developmental
processes to identify Foxh1 and Flk1 to be upstream of Etv2
expression. By utilizing in vitro differentiation of ES cell model,
we demonstrated that Foxh1 deﬁciency leads to a block in FLK1+
mesoderm generation from early “pr” mesoderm. These studies
revealed an unexpected role of Foxh1 beyond the anterior-
posterior patterning in gastrulation. We demonstrated the
potential role of Eomes, one FOXH1 target gene, in FLK1+
mesoderm generation. Recently, npas4l gene was reported to be
upstream of etv2 in zebraﬁsh57. Future studies delineating
upstream pathways that control Etv2 threshold expression are
warranted.
Once achieving the Etv2 threshold expression and the
hemangioblast speciﬁcation, ETV2 may initiate a network critical
for hematopoietic and/or endothelial generation, by activating
key hematopoietic and endothelial cell factors and establishing
the Ets hierarchy10. In particular, upon activation by ETV2, Scl
establishes a transcription factor network that forms a positive
feedback loop, consistent with previous observations16. Given the
critical function of Scl in hematopoietic development, it would be
informative to understand the essential structure of this positive
feedback network. Recently, Goode et al. proposed a core
regulatory network model for hematopoietic speciﬁcation28.
Almost all these core transcription factors, which are direct
targets of ETV210, co-occupy and regulate a large set of hema-
topoietic genes. Among these, coexpression of only SCL and
LMO2 was sufﬁcient to reprogram ﬁbroblasts into hematopoietic
cells28. It should be determined in the future whether the same
group of transcription factors can establish the SCL-positive
feedback loop in the absence of ETV2. Previous studies have
reported that ETV2 and/or other ETS factors can cooperate
with FOXC factors to activate endothelial genes, implying that
ETS and FOXC factors may form an endothelial autoregulatory
network58. Future studies will require identifying a minimal
network(s) that is (are) necessary for hematopoietic and endo-
thelial cell generation.
The unexpected ﬁndings of this study were that Etv2 expres-
sion is initiated independently of FLK1 or VEGF and that VEGF
plays an instructive role in the hemangiogenic fate determination
by conferring Etv2 threshold expression. Accordingly, a potential
positive feedback interaction between Etv2 and FLK1 would
ultimately generate the Etv2highFLK1high state. Cells that reach
the Etv2highFLK1high state are now committed to the heman-
giogenic fate. Therefore, Vegfa, Flk1, and Etv2 form a key
regulatory module in the hemangiogenic fate commitment.
Indeed, genetic knockout studies have established that Vegfa,
Flk1, or Etv2 deﬁciency leads to similar hematopoietic and
endothelial cell formation defects8, 35, 59, 60. In particular,
only FLK1high cells were missing in Etv2-deﬁcient embryos10.
Moreover, Etv2 deletion using the Flk1-Cre system results in
embryonic lethality, apparently showing decreased generation of
the FLK1highPDGFRα− cell population10. This suggests that any
perturbation of the Etv2, VEGF, and FLK1 module causing
insufﬁcient generation of Etv2highFLK1high hemangiogenic
progenitors might lead to defects in hematopoietic and endo-
thelial cell development. Collectively, we propose a two-step
model for the hemangiogenic fate commitment: VEGF-FLK1
signaling-independent Etv2 initiation and VEGF-FLK1 signaling-
dependent Etv2 threshold expression (Fig. 6k). Very rarely, Etv2
threshold expression may also be achieved through intracellular
stochastic mechanisms (as depicted in zigzag lines in Fig. 6k). In
conclusion, VEGF signaling plays an instructive role in heman-
giogenesis, as it enforces new fate acquisition, i.e., hemagniogneic
fate, through promoting Etv2 threshold expression.
Methods
Generation of ES lines. All mouse ES cells were maintained on mouse embryo
ﬁbroblast (MEF) feeder cell layers in Dulbecco-modiﬁed Eagle medium containing
15% fetal bovine serum, 100 units/mL LIF, 1× MEM Non-Essential Amino Acids
Solution (Gibco), 1× GlutamaxTM Supplement (Gibco), and 4.5 × 10–4 M 1-
Thioglycerol (MTG, Sigma). For differentiation, ES cells grown on MEFs were split
onto a gelatin-coated dish in Iscove’s modiﬁed Dulbecco medium (IMDM) with
the same supplements as used for maintenance, and were cultured for 2 days.
Single-cell suspensions were then prepared, and 4000–10,000 ES cells were added
per mL to a differentiation medium of IMDM containing 15% differentiation-
screened fetal calf serum, 1× Glutamax, 50 μg/mL ascorbic acid, and 4.5 × 10–4M
MTG on a bacteriological Petri dish. For serum-free differentiation, FCS was
replaced with 15% knockout SR (Gibco). OP9 cells were grown in α-MEM sup-
plemented with 20% differentiation-screened FCS, 1× Glutamax, 1× NEAA, and
4.5 × 10–4M MTG8, and sorted EB cells growing on OP9 cells were in the same
medium. For ERK inhibition, PD0325901 (Sigma) was added at 2 μM. For serum-
free differentiation of ΔVegfa SGET ES cells, 5% PFHM II (Gibco) was supple-
mented, and mouse BMP4 (BDbiosciences) and VEGF-A (Pepro Tech) were added
as indicated. SGET ES cells were generated by utilizing Scl-EGFP knock-in ES
cells17 and inserting the tdTomato coding sequence after the ETV2 stop codon
using the T2A. Brieﬂy, donor vector containing 1.9 kb upstream (5′-arm) and 2.4
kb downstream (3′-arm) of the ETV2 stop codon were cloned into the pGolden-
Hyg plasmid (Addgene). The stop codon was replaced with the T2A-tdTomato
coding sequence. The sgRNA sequence directing a cut at 13 bp upstream of the
ETV2 stop codon was inserted into the CRISPR plasmid PX330 (Addgene,
deposited by Feng Zhang’s lab). Donor vector and CRISPR plasmid were
cotransfected into Scl-EGFP knock-in ES cells using the Lonza nucleofection kit.
Hygromycin was added 24 h later (200 μg/mL, Sigma) and selected for 7 days.
Hygromycin-resistant clones were picked and identiﬁed by PCR and sequencing.
The hygromycin-resistance cassette was subsequently excised by nucleofection of
the cells with Cre61. The sgRNA sequence for targeting Etv2 locus and primers used
to identify the correctly targeted clones are listed in Supplementary Table 1. TGET
ES cells were generated by utilizing Brachyury/EGFP knock-in ES cells18 and the
same strategy for generating SGET cells. Inducible ES cell lines (iEtv2-mCherry,
iFoxh1, and iEomes) were generated by targeting the tet-responsive locus of
A2Lox/Scl-hCD4 cells61, with the construct containing the coding sequence of
Etv2-mCherry, Foxh1, or Eomes, as described previously. For generating homo-
zygous/heterozygous knockout ES cell lines, ES cells were ﬁrst transduced with
lenti-Cas9-Blast (Addgene, deposited by Feng Zhang Lab) and selected using
blasticidin (Sigma, 2 μg/mL). Single clones were picked for identiﬁcation of Cas9
expression and normal differentiation. sgRNAs were cloned into lentiGuide-Puro
(Feng Zhang Lab) or pKLV-U6gRNA_BbsI_PGKPuro2ABFP62 that coexpresses
blue ﬂuorescent protein (BFP) with the sgRNA. The cells were infected with len-
tiviruses expressing sgRNA against the target gene. The cells were selected with
puromycin (Sigma, 1 μg/mL) for at least 7 days and then single clones were picked
and identiﬁed by sequencing. The sgRNAs used to identify the mutations are listed
in the Supplementary Table 1.
Flow cytometry and sorting. EBs were dissociated with Accutase solution
(Sigma). E7.5 embryos were ﬁrst digested in 0.25% collagenase and 20% FBS, then
in accutase solution. Single cells were incubated with α-human CD4 (Biolegend),
α-mouse FLK1 (BioLegend or eBioscience), α-mouse PDGFRα (BioLegend),
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α-mouse CD41 (eBioscience) or α-mouse TIE2 (eBioscience). Data were acquired
on the FACS Canto II or LSR-Fortessa ﬂow cytometer (BDbiosciences) and
analyzed using the FlowJo (Treestar) software. Cell sorting was performed using
the BD FACSAria II system.
Blast colonies formation cell assay. Sorted EB cells were replated in methyl
cellulose containing 10% plasma-derived serum (PDS, Antech; Texas), 5%
PFHM II, 1× Glutamax, 1× BIT9500 (STEMCELL Technologies) and MTG
(4.5 × 10–4M), together with kit ligand (1% conditioned medium). Blast colonies
were counted 4 days later15.
RNA-seq analysis. Total RNA was extracted using the RNeasy Mini kit (Qiagen).
Library preparation was performed with 10 ng of total RNA (GTAC core facility,
Washington University in St. Louis): Total RNA integrity was validated using an
Agilent bioanalyzer. All samples were prepared using the Ribozero (Epicentre) kit
as per the manufacturer’s protocol. cDNA was then blunt ended, an A base added
to the 3′ ends, and then Illumina sequencing adapters were ligated to the ends.
Ligated fragments were then ampliﬁed for 12 cycles using primers incorporating
unique index tags. Fragments were sequenced on an Illumina HiSeq-2500 using
single reads extending 50 bases. RNA-seq reads were aligned to the mouse mm9
assembly from the UCSC Genome Browser with Tophat263. Gene counts were
derived from the number of uniquely aligned unambiguous reads by Subread:
featureCount version 1.4.564. All gene-level counts were then imported into the
R/Bioconductor package EdgeR normalized to adjust for differences in library size.
Genes with RPKM <5 in all samples were excluded from further analysis. Genes
with of less than ﬁvefold changes in any two samples were also excluded. Finally,
3815 genes were used for further presentation. Published data used in RNA-seq
analysis: GSE57409 (sample “ES” and “EpiSC”), GSE36114 (sample “endo_d6”,
representing ES cell for endoderm differentiation on day 6), GSE69080 (“mes”,
“hb”, “hp”), GSE55310 (“he”), 7R2 (https://b2b.hci.utah.edu/gnomex/, sample “cp”,
representing ES cells differentiated to cardiac progenitors25). The RNA-seq data
have been deposited in the NCBI Gene Expression Omnibus (GEO) database under
accession code GSE85641.
Zipcode mapping. Zipcode mapping was performed as described in the
developers’ manual27 (www.itranscriptome.org/). Brieﬂy, after uploading
transcriptome data of our samples to the website, expression values of 158
preselected landmark genes of the E7.0 gastrulating embryo were extracted.
Then a matrix of Spearman rank correlation coefﬁcients of the transcriptome
of a given sample to those of different regions in the gastrulating embryo was
returned from the website.
CRISPR genetic screening and data analysis. CRISPR screening was performed
as previously described11. Brieﬂy, TGET ES cells were stably transduced with
lenti-Cas9-Blast and selected using blasticidin (2 ng/mL). Subsequently, 2.4 × 107
TGET ES cells constitutively expressing Cas9 were infected with the GeCKO
CRISPR lentivirus library at a MOI of 0.2 (200× coverage of the library). Cells were
selected with puromycin and maintained in ES medium for 2 weeks, followed by
differentiation and cell sorting. Cell numbers in each sample for genomic DNA
extraction ensured at least 100× coverage of the library. Genomic DNA extraction
and sgRNA library ampliﬁcation were performed faithfully following the previously
described protocol11. Sequencing data preprocess was also performed as described
in the same protocol. The read counts of each sgRNA sequence were imported to
HiTSelect30 to obtain gene lists with signiﬁcance of sgRNA depletion in treated
samples compared to control samples. Functional annotation of gene lists was
performed with ConsensusPathDB (http://cpdb.molgen.mpg.de/MCPDB). The
CRISPR screen reads data have been deposited in the NCBI Gene Expression
Omnibus (GEO) database under accession code GSE85641. DNA sequences for
primers and sgRNAs listed in Supplementary Table 1.
Gene set enrichment analysis. Gene set enrichment analysis (GSEA) analysis was
carried out using the GSEA software from the Broad Institute40. Genes were ranked
by the downregulation fold in Foxh1 knockout “pr” cells compared to wt “pr” cells.
Genes with expression correlated to T in early gastrulation embryo41 (correlation
score >0.2) were used as the test gene sets for analysis of enrichment.
Quantitative real-time reverse transcription PCR. Total RNA from embryos
or EB cells was prepared with RNeasy Micro/Mini Kit (Qiagen), and reverse
transcribed into cDNAs according to the manufacturer’s protocol. Expression of
genes was measured by quantitative real-time RT-PCR using primers indicated in
Supplementary Table 1. Gene expression levels were normalized to Gapdh.
Live imaging. SGET D3 EBs were transferred onto Matrigel-coated glass bottom
dish for 24 h, followed by live imaging. VEGF was added at 50 ng/mL and the cells
were maintained in a 5% CO2 wet chamber ﬁtted onto the Nikon a1 confocal
microscope. Live images were captured every 30 min.
Statistical analysis. The results of qRT-PCR and ﬂow cytometry analysis were
analyzed by Students’ t test. P< 0.05 was considered signiﬁcant.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its supplementary information ﬁles or
from the corresponding author on reasonable request. The RNA-seq data and
CRISPR screen reads counting data reported in this paper have been deposited in
NCBI GEO under accession code GSE85641.
Published data used in RNA-seq analysis include the following already
deposited data sets: GSE57409 (sample “ES” and “EpiSC”), GSE36114
(sample “endo_d6”, representing ES cell for endoderm differentiation on day 6),
GSE69080 (“mes”, “hb”, “hp”), GSE55310 (“he”), 7R2 (https://b2b.hci.utah.edu/
gnomex/, sample “cp”, representing ES cells differentiated to cardiac
progenitors25).
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